1 |
Anderson NE, Budde-Steffen C, Wiley RG, et al. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration [J]. Neurlogy, 1988, 38(7): 1018-1026.
|
2 |
Guan HZ, Ren HT, Peng B, et al. Anti-Yo antibody-associated paraneoplastic cerebellar degeneration: a report of 6 patients [J]. Chin J Neurol, 2015, 48(2): 89-93.
|
3 |
Cuartero IG, Galdeano MR, Pinar MP, et al. Thymic carcinoma associated with cerebellar degeneration[J]. Eur J Case Rep Intern Med,2018, 5(3): 000780.
|
4 |
Yan L, Dong X, Xu H, et al. Paraneoplastic cerebellar degeneration associated with breast cancer: a case report and review of the literature[J]. Mol Clin Oncol, 2018, 9(2): 163-167.
|
5 |
关鸿志. 自身免疫性小脑共济失调的诊治 [J]. 中华神经志, 2024,57(6): 642-648.
|
6 |
Yshii L, Bost C, Liblau R. Immunological bases of paraneoplastic cerebellar degeneration and therapeutic implications [J]. Front Immunol, 2020, 11: 991.
|
7 |
Monstad SE, Storstein A, Dørum A, et al.Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique [J]. Clin Exp Immunol, 2006, 144(1): 53-58.
|
8 |
Hashimoto Y, Komatsu K, Nakagawa T, et al. Transient diffusion-weighted imaging hyperintensity of the cerebellar cortex in paraneoplastic cerebellar degeneration [J]. Intern Med, 2019, 58(4):619-620.
|
9 |
Graus F, Vogrig A, MuñizCastrillo S, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes [J]. Neurol Neuroimmunol Neuroinflamm, 2021, 8(4): e1014.
|
10 |
Hens MJ, Camacho B, Maestre A, et al. Carcinoma renal que debuta como cuadro neurológico paraneoplásico [J]. Actas Urol Esp, 2008,32(6): 645-648.
|
11 |
Souza SM, Santos BO, Sodré ICA, et al. Paraneoplastic cerebellar degeneration as initial presentation of renal cell carcinoma [J].Cerebellum Ataxias, 2019, 6(1):1-3.
|
12 |
Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplasticcerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients [J]. Brain, 2003, 126(6): 1409-1418.
|
13 |
高君伟, 刘皋林. 自身免疫性疾病的药物治疗 [J/OL]. 中华临床医师杂志(电子版), 2023, 17(12): 1209-1211.
|
14 |
Zhou Q, Yin D, Ma J, et al. The therapeutic effect of ofatumumab in autoimmune encephalitis: A case series [J]. J Neuroimmunol, 2023,377: 578062.
|
15 |
Yeo KK, Walter AW, Miller RE, et al. Rituximab as potentialtherapy for paraneoplastie cerebellar degeneration in pediatricHodgkin disease[J]. Pediatr Blood Cancer, 2012, 58(6): 986-987.
|